SCHEMBL3845229

SCHEMBL3845229

O=C(Nc1ccc(Cl)cn1)c1ccc(-c2cnc3ccc(-c4cnn(C(c5ccccc5)(c5ccccc5)c5ccccc5)c4)cn23)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
SORT1 Q99523 1/20 0.40
CLK1 P49759 4/20 0.40
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
F10 P00742 3/20 0.38
KCNH2 Q12809 1/20 0.38
ALOX15 P16050 1/20 0.38
HTT P42858 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
RIPK1 Q13546 1/20 0.37
FLT3 P36888 1/20 0.37
MET P08581 1/20 0.37
TSHR P16473 2/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850098 0.90 EPHB3 (0.39) SMN1; SMN2CLK1NPC1RAB9AMEN1
SCHEMBL3847111 0.89 CLK1 (0.41) CLK1MKNK1MKNK2MET
SCHEMBL3846503 0.89 CLK1 (0.37) SMN1; SMN2TDP1CLK1NPC1RAB9A
SCHEMBL3846174 0.88 EPHB3 (0.39) SMN1; SMN2TDP1CLK1MKNK1MKNK2
SCHEMBL3848378 0.88 EPHB3 (0.38) SMN1; SMN2TDP1CLK1NPC1RAB9A
SCHEMBL3847500 0.87 CLK1 (0.37) CLK1FLT3MET
SCHEMBL3848640 0.87 KCNQ3 (0.39) CLK1MET
SCHEMBL3845914 0.86 MAPK1 (0.42) SMN1; SMN2CLK1NPC1RAB9AMEN1
SCHEMBL3845025 0.86 SORT1 (0.41) SMN1; SMN2SORT1CLK1NPC1RAB9A
SCHEMBL3846961 0.85 TRPV1 (0.47) CLK1MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed